No Data
Meinian Onehealth to Pay Deposit for Bangjie's Capital Reserves
A-Share Market Movement | Meinian Health Drops Nearly 4% as Shareholder Plans to Sell Up to 3% Stake, Facing Pressure After Yesterday’s Surge of Over 7%
Gelonghui, May 29 | Meinian Health (002044.SZ), which surged more than 7% yesterday, retreated nearly 4% to close at RMB 5.67, giving it a total market capitalization of RMB 22.19 billion. According to an announcement, Meinian Health disclosed a share reduction plan, stating that shareholder Hangzhou Haoyue Enterprise Management Co., Ltd. intends to sell no more than 117.4276 million shares, representing up to 3% of the company’s total share capital. Additionally, it is reported that the company has issued two such share reduction announcements over the past three years. It should be noted that the number of shares indicated for potential reduction in the announcement does not necessarily reflect the final actual number of shares sold.
Molybdenum industry leader clarifies after two daily trading limits in three days: rumors about chip suppliers and large orders are unfounded | Selected Post-Market Announcements
The global molybdenum industry leader has issued a trading risk warning; 'the first mattress stock' announced a major litigation notice; and this brain-computer interface concept stock received an administrative regulatory measures decision letter...
Express News | Meinian Health: Shareholder Hangzhou Haoyue plans to reduce its stake by no more than 3% of the company's shares.
Meinian Health (002044): Q1 Revenue Under Short-Term Pressure; Deepening AI Strategy Expected to Support Performance Improvement
Key View: The company's 2025 performance met expectations. Revenue in Q1 2026 was slightly below expectations, while profit was in line with expectations. The company's Q1 2026 revenue faced short-term pressure due to the Lunar New Year seasonal slowdown, but the loss narrowed year-over-year through further cost reduction and efficiency enhancement measures.
Stock Movement | Baize Medical (02609) Rises Over 4% as Subsidiary Signs Strategic Cooperation Agreement with Meinian Onehealth to Strengthen Implementation of H@H Service Model
Baize Medical (02609) surged over 4% during the trading session. As of the time of writing, it was up 2.1%, trading at HKD 5.35, with a turnover of HKD 42.315 million.